RecruitingNCT06602648

MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)

Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults. Histological, Computational, and Molecular Pathology for Improved Diagnosis. (Mol-Mel). Work Package 3 (WP3)


Sponsor

University of Florence

Enrollment

100 participants

Start Date

Apr 17, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to investigate a type of skin cancer, also known as melanoma, in children, adolescents, and young adults, who will be referred to as CAYA patients in this project. The need for this study arises because this disease, in CAYA patients, is still poorly understood due to its rarity in individuals under 30 years old. This often leads to difficulties in assessing its severity and, consequently, in deciding on the necessary treatments to ensure the patient\'s recovery. The goal of this study is to examine melanoma in CAYA patients in order to gather the information needed to provide better diagnoses for affected patients and, as a result, select appropriate treatments to fight the disease and promote the patient\'s full recovery. Additionally, the data collected will be used to create a Pan-European online platform that will allow doctors across the European Union to consult the obtained data and collaborate on particularly complex melanoma cases, always with the aim of ensuring the patient\'s full recovery in the shortest possible time.


Eligibility

Max Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data and biological samples from children, teenagers, and young adults (under 30) diagnosed with melanoma or unusual mole-like tumours, to better understand how these cancers behave in younger patients and improve future care. **You may be eligible if...** - You are under 20 years old (child or adolescent) or under 30 years old (young adult) - You have been confirmed by biopsy to have melanoma or an ambiguous/intermediate melanocytic tumour (a type of unusual mole-like growth) **You may NOT be eligible if...** - You are 30 years of age or older - You do not have a histologically confirmed diagnosis of melanoma or an ambiguous melanocytic tumour Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Florence

Florence, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06602648


Related Trials